Loading insider details...
Latest Form 4 (Aug 20, 2026): Sale of 604 ACRV shares, $1.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 604 | $1.2K |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 72,981 | n/a |
| May 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 613 | $1.2K |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 186,728 | n/a |
| Feb 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 723 | $1.2K |
| Jan 15, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Purchase | 10,000 | $17.2K |
| Nov 18, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 613 | $1.4K |
| Aug 18, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 613 | $852.07 |
| May 16, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 613 | $698.82 |
| Mar 4, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 140,540 | n/a |